How Cineplex Stock Could Skyrocket Into Year’s End, Even Amid Rising COVID-19 Cases

Cineplex (TSX:CGX) has a secret weapon to stabilizing its cash flows, as COVID-19 variants of concern continue to cause excess levels of volatility.

| More on:
movies, theatre, popcorn

Image source: Getty Images

The insidious Delta variant of COVID-19 has caused some considerable pressure on the reopening plays, such as Cineplex (TSX:CGX) stock, especially those that felt the worst impact during the intermittent lockdowns suffered over the past 20 months. Indeed, the pandemic isn’t over yet. Public health experts don’t even expect COVID-19 to be eradicated — at least not anytime soon. While I suspect the Delta wave will peak over the coming weeks, which could give reopening plays a bit of a boost, there’s still no telling what’s next. Could another variant, such as Lambda, cause the next lockdown?

COVID-19 risks ahead

Is it virulent or infectious enough to classify as a variant of concern? And could it evade the current slate of COVID-19 vaccines and their boosters, which aim to target Delta? These are the questions that we don’t yet know.

We will learn more about future variants as they come along and as scientists gather more information. But for now, there’s still a haze of darkness that’s clouding the future of this pandemic. As such, I wouldn’t overweight a substantial portion of your portfolio in aggressive reopening stocks without a proper balance of plays that are capable of withstanding another round of lockdowns. Specifically, I’d be wary of names that are bleeding cash, with unhealthy balance sheets that could find themselves on life support should we be hit with a particularly bad wave of COVID-19 at some point over the next 18 months.

Is it too soon to bet big on Cineplex given COVID-19 uncertainties?

While I wouldn’t back up the truck on the latest Delta-variant-driven bout of weakness, I would look to nibble as shares are likely to continue higher, as Canada winds down from its Delta wave potentially in mid- to late September. With an election up ahead, we could see parties double down on their efforts to curb the spread of the insidious coronavirus. Vaccine passports, testing, and all the sort will be a hot topic for debate as Canadians head to the polls, potentially amid a Delta-driven wave.

Undoubtedly, Cineplex has been doing everything under its own power to ensure the safety of its patrons. They’ve done a great job, given the dire situation. And while the balance sheet isn’t as good as I’d like, I still think the worst is behind the ailing movie theatre chain.

CineClub could smoothen Cineplex stock’s recovery

There are catalysts to get excited about. Most notably, CineClub, a subscription service aimed at frequent moviegoers, could help the company fill its seats with bums again at a quicker rate while securing a steadier revenue stream. The subscription, which goes for $9.99 a month, is a pretty good deal, especially for vaccinated individuals who are sick of staying at home to watch films.

Once COVID-19 ends, the movie theatre business, I believe, will be alive and well, as it enjoys pent-up demand for the silver screen, potentially at the expense of the video streamers. The CineClub monthly fee offers a general admission movie ticket per month alongside a slew of great discounts at the concession and across Cineplex’s other attractions, like the Rec Room.

I think CineClub will be a hit. And as more people get vaccinated, I think Cineplex could be on the cusp of an epic rebound that future variants will not be able to stop.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool recommends CINEPLEX INC.

More on Coronavirus

Airport and plane

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »

telehealth stocks
Tech Stocks

The Ultimate Growth Stock to Buy With $100 Right Now

After climbing 600%, this growth stock is now down 68%. But it won't be long before other investors catch on.

Read more »

consider the options

Is Now the Perfect Time to Buy Cineplex Stock (TSX:CGX)?

Cineplex stock is significantly undervalued as it's shunned by investors. Yet, the business is showing great strength.

Read more »

A stock price graph showing declines
Dividend Stocks

Here’s Why I’m Confident About Investing Through the Down Market

There is no bear market in history that has not been followed by a bull cycle. Rather than fret over…

Read more »

Doctor talking to a patient in the corridor of a hospital.

3 Top TSX Healthcare Stocks to Buy in October

Healthcare stocks soared during the pandemic, and are now down in the dumps. But these three could make a huge…

Read more »